Literatur
- 01
Ekberg H, et al.
N Engl J Med.
2007;
357
2562-2575
- 02
Meier-Kriesche H U, et al.
Am J Transplant.
2006;
6
1111-1131
- 03
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group .
Am J Transplant.
2009;
9 (Suppl. 3)
S1-S157
- 04
Ekberg H, et al.
Am J Transplant.
2009;
9
1876-1885
- 05
Opelz G, Döhler B.
Transplantation.
2008;
86
371-376
- 06
Borra LCP, et al.
Nephrol Dial Transplant.
2010;
25
2757-2763
- 07
Berggren S, et al.
Mol Pharm.
2007;
4
252-257
- 08
Canaparo R, et al.
Clin Exp Pharmcol Physiol.
2007;
34
1138-1144
- 09 Data on File, Astellas Pharma.
- 10
Alloway R, et al.
Transplant Proc.
2005;
37
867-870
- 11
Floman S, et al.
Transplant Proc.
2005;
37
1211-1213
- 12
Vlaminck H, et al.
Am J Transplant.
2004;
4
1509-1513
- 13
Butler J A, et al.
Transplantation.
2004;
77
786-789
- 14
Weng F L, et al.
J Am Soc Nephrol.
2005;
16
1839-1848
- 15 Krämer B K, et al. 2010 Sep 14. doi: 10.1111/j.1600-6143.2010.03256.x. [Epub ahead
of print].
- 16 Krämer B K, et al. DTG 2010; Poster P 057.
- 17 Krämer B K, et al. DTG 2010; Poster P 058.
01 Efficacy Limiting Toxicity Elimination
